Free shipping on all orders over $ 500

BI 6727

Cat. No. M1678

All AbMole products are for research use only, cannot be used for human consumption.

BI 6727 Structure
Synonym:

Volasertib

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 110  USD110 In stock
5mg USD 87  USD87 In stock
10mg USD 155  USD155 In stock
50mg USD 500  USD500 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

BI 6727 (Volasertib) is a small highly potent Polo-like kinase inhibitor (Plk)  with an IC50 of 0 .87 nM and EC50 of 11-37 nM on a panel of cancer cell lines, which exhibited significant anti-proliferative in multiple cancer models, including a model of taxane-resistant colorectal cancer. BI 6727 (Volasertib) caused programmed cell death in colon and non-small cell lung cancer cells both in vitro and in vivo.

Customer Product Validations & Biological Datas
Source Target Oncol (2015). Figure 1. BI 6727
Method Western blotting
Cell Lines TC-71 cells
Concentrations 15 nM
Incubation Time 48 hr
Results We found that BI 6727/VCR-mediated apoptosis was significantly decreased in the presence of zVAD.fmk in four of the five tested ES cell lines, while the tendency of zVAD.fmk to reduce BI 6727/ VCR-induced apoptosis in TC-71 ES cells did not reach statistical significance
Source Target Oncol (2015). Figure 1. BI 6727
Method Apoptosis assay
Cell Lines ES cells
Concentrations 15 nM
Incubation Time 48 h
Results Interestingly, suboptimal doses of BI 6727 and VCR synergized to trigger DNA fragmentation, used as a typical parameter to assess apoptosis
Protocol (for reference only)
Cell Experiment
Cell lines HCT116 and NCI-H460 cells
Preparation method Cell culture and proliferation assays. Cancer cell lines were obtained from the American Type Culture Collection or the German National Resource Center for Biological Material and were cultured according to the supplier’s instructions. Cell proliferation assays were done by incubating cells in the presence of various concentrations of BI 6727 for 72 h and cell growth was assessed by measuring Alamar blue dye (Serotec) conversion in a fluorescence spectrophotometer. Effective concentrations at which cellular growth was inhibited by 50% (EC50) were extrapolated from the dose-response curve fit.
Concentrations 0~100µM
Incubation time 72 h
Animal Experiment
Animal models nude mice bearing established HCT116 human colon carcinoma tumors xenograft model
Formulation formulated in hydrochloric acid (0.1 N), diluted with 0.9% NaCl
Dosages 40 mg/kg
Administration i.v. into the tail vein
Chemical Information
Molecular Weight 618.81
Formula C34H50N8O3
CAS Number 755038-65-4
Solubility (25°C) DMSO 50 mg/mL
Storage 2-8°C, protect from light
References

[1] Schöffski et al. Eur J Cancer. A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours.

[2] Grinshtein et al. Cancer Res. Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells.

[3] Rudolph et al. Clin Cancer Res. BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity.

Related PLK Products
(1E)-CFI-400437 dihydrochloride 

(1E)-CFI-400437 dihydrochloride is a potent PLK4 (IC50= 0.6 nM) inhibitor and selective against other members of the PLK family (>10 μM).

3MB-PP1

3MB-PP1 is a bulky purine analog and inhibitor of Polo-like kinase 1 (Plk1) that blocks mitotic progression and cytokinesis by targeting Plk1 in cells expressing the analog-sensitive Plk1 allele. 3MB-PP1 also specifically inhibits the activity of Leu93 mutant Zipper-interacting Ssn3 (Cdk8). 3MB-PP1 inhibits the activity of Leu93 mutant Zipper-interacting Ssn3 (Cdk8). In addition, 3MB-PP1 specifically inhibits the activity of analog-sensitive Ssn3 (Cdk8). 3MB-PP1 inhibits the Leu93 mutant Zipper-interacting protein kinase (Leu93-ZIPK; IC50=2 μM). 3MB-PP1 can be used in the mycelium of Candida albicans. 3MB-PP1 can be used in studies related to mycelium formation and cell division in Candida albicans.

CYC-800

CYC-800 is a PLK1 inhibitor that can be used in tumor-related studies.

SOL-686

SOL-686 is a PLK1 inhibitor that can be used in glioma-related studies.

BAL0891

BAL0891 is a potential first-in-class PLK1/TTK inhibitor with antiproliferative activity for studies related to solid tumors.

  Catalog
Abmole Inhibitor Catalog




Keywords: BI 6727, Volasertib supplier, PLK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.